Preparation method of indolone substituted isocoumarin compound
Through palladium-catalyzed domino Heck tandem cyclization reaction, the efficient synthesis of indolone-substituted isocoumarin compounds was successfully achieved, solving the problem of lack of synthesis methods for such compounds in the prior art, and is highly efficient, specific and operational Simple features, suitable for the research and development of new drugs and new materials.
Patent Information
- Application Number
- CN202410598479.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-05-14
- Publication Date
- 2024-11-08
AI Technical Summary
The prior art lacks efficient synthesis methods for indolone-substituted isocoumarin compounds, which limits the application of such compounds in the development of biological activity and medicinal properties.
Domino Heck tandem cyclization reaction catalyzed by palladium catalyzed, using allyl palladium and triphenylphosphine chloride as catalysts and potassium carbonate as base, N-(2-iodophenyl)-N-methyl in acetonitrile solvent Acrylamide reacts with 2-ethynylbenzaldehyde to achieve the efficient synthesis of indolone-substituted isocoumarin compounds.
It has achieved high efficiency, specificity and atomic economy of indolone-substituted isocoumarin compounds, has a wide range of substrate application, is suitable for the research and development of new drugs and new materials, is easy to operate and has few by-products.
Smart Images

Figure SMS_1 
Figure SMS_2 
Figure SMS_3
Abstract
Description
Technical Field
[0001] The invention belongs to the field of organic synthesis, and in particular relates to a method for preparing an indole ketone-substituted isocoumarin compound. Background Art
[0002] Combining molecules with different biological activities is an important method for discovering or designing modern drugs. Therefore, in organic synthesis, it is of great significance to construct compound molecules with different biological activities in one step. 3,3-disubstituted indolones and isocoumarins are valuable structures with biological and pharmacological activities in many compounds. Therefore, integrating isocoumarins into the 3,3-disubstituted indolone skeleton may improve its biological activity or create new medicinal properties. Therefore, it is very necessary to develop a reliable method for synthesizing isocoumarin compounds that can contain indolone substitutions. However, the synthesis method of these novel indolone-substituted isocoumarin compounds has not been reported yet. This has greatly restricted the application of such compounds in various fields. The present invention provides a simple and efficient preparation method for indolone-substituted isocoumarin compounds. Summary of the invention
[0003] The purpose of the present invention is to provide a method for preparing an indolone-substituted isocoumarin compound by a one-step synthesis with high efficiency and mildness through a palladium-catalyzed domino Heck tandem cyclization reaction, wherein the method has the characteristics of high product specificity, few by-products and a wide range of substrate applicability.
[0004] The technical scheme of the method of the present invention is as follows:
[0005] A method for synthesizing an indolinone-substituted isocoumarin compound, wherein an N-(2-iodophenyl)-N-methylacrylamide compound (Formula I) and a 2-ethynylbenzaldehyde compound (Formula II) are reacted in an organic solvent under an argon atmosphere, under the catalysis of a catalyst and a ligand, and in the presence of a base to obtain various indolinone-substituted isocoumarin compounds (Formula III), and the reaction formula is as follows:
[0006]
[0007] In the above reaction formula: R 1 For various halogens and alkyl groups, R 2 is an alkyl group or a benzyl group, R 3 For various halogens and alkyl groups, R 4 It is an alkyl group, an aromatic heterocyclic group, a phenyl group and various substituted phenyl groups, and X is a nitrogen or oxygen atom.
[0008] The above-mentioned halogen refers to a fluorine or chlorine atom.
[0009] The catalyst used in the method of the present invention is allylpalladium (II) chloride dimer, which can be a commercial reagent and does not require special treatment; the dosage is preferably 10% equivalent based on the 2-ethynylbenzaldehyde.
[0010] The ligand used in the method of the present invention is triphenylphosphine, which can be a commercial reagent and does not require special treatment; the dosage is preferably 20% equivalent based on the 2-ethynylbenzaldehyde.
[0011] The base used in the method of the present invention is potassium carbonate, which can be a commercial reagent and does not require special treatment; the amount used is preferably 2.5 equivalents based on the 2-ethynylbenzaldehyde.
[0012] The organic solvent used in the method of the present invention is preferably acetonitrile. The amount of the organic solvent used is calculated based on 10 ml of organic solvent per millimole of 2-ethynylbenzaldehyde.
[0013] The preferred molar ratio of the two reactants in the method of the present invention is N-(2-iodophenyl)-N-methylacrylamide compound:2-ethynylbenzaldehyde compound=2.5:1.
[0014] The reaction temperature of the above reaction is 80° C. and the reaction time is 20 hours. The heating process can be carried out by using an oil bath (such as silicone oil, paraffin oil, etc.) or other heating methods.
[0015] The method of the present invention realizes the one-pot synthesis of indolone-substituted isocoumarin compounds by palladium-catalyzed tandem Heck cyclization reaction for the first time. The method has the advantages of high reaction efficiency, good economy, and a wide range of substrate applications, and can be widely used in the preparation of various indolone-substituted isocoumarin compounds. Specifically, the present invention has the following advantages:
[0016] 1. The indolinone-substituted isocoumarin compounds prepared by the present invention have potential application value in the fields of organic synthesis, new drugs and new material research and development;
[0017] 2. No by-products are generated during the synthesis process of the present invention, and the atom economy is high;
[0018] 3. The present invention has the characteristics of simple operation and good specificity;
[0019] 4. The raw materials involved in the method of the present invention are simple and easy to obtain; DETAILED DESCRIPTION
[0020] The present invention is further described below in conjunction with embodiments, but the scope of implementation of the present invention is not limited in any way.
[0021] Example 1
[0022] Synthesis of 1,3,5-trimethyl-3-((1-oxo-3-phenyl-1H-isochromen-4-yl)methyl)indolin-2-one
[0023] To a 10 mL glass reaction bottle, 158 mg (ie 0.5 mmol) of N-(2-iodo-4-methylphenyl)-N-methylacrylamide, 41 mg (ie 0.2 mmol) of 2-phenylethynylbenzaldehyde, 7 mg (ie 0.02 mmol) of allylpalladium (II) chloride dimer, 10 mg (ie 0.04 mmol) of triphenylphosphine, and 69 mg (ie 0.5 mmol) of potassium carbonate were added in sequence, and 2 mL of acetonitrile was added. The argon gas was replaced three times, and the mixture was stirred at 80 ° C for 20 hours. After the reaction, the mixture was concentrated and the eluent was petroleum ether: ethyl acetate in a volume ratio of 5:1. The mixture was purified by silica gel column chromatography to obtain 1,3,5-trimethyl-3-((1-oxo-3-phenyl-1H-isochromen-4-yl)methyl)indolin-2-one, the structure of which is shown in the following formula:
[0024]
[0025] The compound is a white solid with a yield of 66%. Its NMR data are as follows:
[0026] 1 H NMR (600 MHz, CDCl 3 )δ8.27(dd,J=7.8,1.4Hz,1H),7.70-7.63(m,2H),7.48(s,1H),7.44(q,J=3.0Hz,3H),7.43-7.39(m,2H),6.56(d,J=7.5 Hz,1H),6.40(s,1H),6.30(d,J=7.5Hz,1H),3.52(s,1H),3.42(d,J=14.9Hz,1H),2.86(s,3H),2.30(s,3H),1.24(s,3H). 13 C NMR (151 MHz, CDCl 3 )δ180.42,162.06,154.09,142.73,137.98,137.63,133.81,133.51,130.13,129.48,129.41,129.21, 128.30,127.83,124.87,123.67,122.69,120.34,110.28,108.56,48.69,33.65,25.85,23.72,21.67.
[0027] Example 2
[0028] Synthesis of 1-Benzyl-3-methyl-3-((1-oxo-3-phenyl-1H-isochromen-4-yl)methyl)indolin-2-one
[0029] To a 10 mL glass reaction bottle, 188 mg (ie 0.5 mmol) of N-benzyl-N-(2-iodophenyl) methacrylamide, 41 mg (ie 0.2 mmol) of 2-phenylethynylbenzaldehyde, 7 mg (ie 0.02 mmol) of allylpalladium (II) chloride dimer, 10 mg (ie 0.04 mmol) of triphenylphosphine, and 69 mg (ie 0.5 mmol) of potassium carbonate were added in sequence, and 2 mL of acetonitrile was added. The argon gas was replaced three times, and the mixture was stirred at 80 ° C for 20 hours. After the reaction, the mixture was concentrated and the eluent was petroleum ether: ethyl acetate in a volume ratio of 5:1. The mixture was purified by silica gel column chromatography to obtain 1-benzyl-3-methyl-3-((1-oxo-3-phenyl-1H-isochromen-4-yl)methyl)indolin-2-one, and its structure is shown in the following formula:
[0030]
[0031] The compound is a black liquid with a yield of 81%. Its NMR data are as follows:
[0032] 1 H NMR (600 MHz, CDCl 3 )δ8.31(dd,J=7.9,1.5Hz,1H),7.76(d,J=8.2Hz,1H),7.66-7.61(m,1H),7.47(t,J=7.6Hz,1H),7.4 1(td,J=8.7,4.6Hz,3H),7.35(dd,J=7.6,1.9Hz,2H),7.24-7.21(m,3H),7.01(t,J=7.7Hz,1H),6.90 (dd,J=6.6,3.0Hz,2H),6.69(t,J=7.6Hz,1H),6.49(d,J=7.8Hz,1H),6.40(d,J=7.5Hz,1H),4.76(d, J=15.7Hz,1H),4.50(d,J=15.7Hz,1H),3.67(d,J=14.9Hz,1H),3.50(d,J=14.9Hz,1H),1.35(s,3H). 13 CNMR (151MHz, CDCl 3)δ179.94,162.01,154.33,141.97,137.58,135.61,134.06,133.56,132.12,129.99,129.45,128.77,128.39, 128.04,127.76,127.49,126.82,125.07,123.90,122.46,120.43,109.96,108.79,49.00,43.60,33.20,24.47.
[0033] Example 3
[0034] Synthesis of 4-((3-methyl-2,3-dihydrobenzofuran-3-yl)methyl)-3-phenyl-1H-isochromen-1-one
[0035] To a 10 mL glass reaction bottle, 137 mg (ie 0.5 mmol) of 1-iodo-2-((2-methylallyl)oxy)benzene, 41 mg (ie 0.2 mmol) of 2-phenylethynylbenzaldehyde, 7 mg (ie 0.02 mmol) of allylpalladium (II) chloride dimer, 10 mg (ie 0.04 mmol) of triphenylphosphine, and 69 mg (ie 0.5 mmol) of potassium carbonate were added in sequence, and 2 mL of acetonitrile was added. The argon gas was replaced three times, and the mixture was stirred at 80 ° C for 20 hours. After the reaction, the mixture was concentrated and the eluent was petroleum ether: ethyl acetate in a volume ratio of 10:1. The mixture was purified by silica gel column chromatography to obtain 4-((3-methyl-2,3-dihydrobenzofuran-3-yl)methyl)-3-phenyl-1H-isobenzopyran-1-one, and its structure is shown in the following formula:
[0036]
[0037] The compound is a yellow liquid with a yield of 57%. Its NMR data are as follows:
[0038] 1 H NMR (600 MHz, CDCl 3 )δ8.34(d,J=7.9Hz,1H),7.57-7.49(m,3H),7.46(q,J=4.5,3.1Hz,4H),7.28(s,1H),7.02(t,J=7.3Hz,1H),6.69(d,J= 8.0Hz,1H),6.60(s,2H),4.24(d,J=8.7Hz,1H),3.90(d,J=8.7Hz,1H),3.32(d,J=14.7Hz,1H),3.25(d,J=15.0Hz,1H). 13 CNMR (151MHz, CDCl 3)δ162.20,159.32,154.00,138.48,134.01,133.92,129.86,129.62,129.48,128.58,128. 36,127.71,124.01,123.39,120.59,120.51,110.56,109.80,82.82,47.22,34.63,24.08.
[0039] Example 4
[0040] Synthesis of 3-((6-fluoro-1-oxo-3-phenyl-1H-isochromen-4-yl)methyl)-1,3-dimethylindolin-2-one
[0041] To a 10 mL glass reaction bottle, 152 mg (ie 0.5 mmol) of N-(2-iodophenyl)-N-methylmethylacrylamide, 45 mg (ie 0.2 mmol) of 4-fluoro-2-(phenylethynyl)benzaldehyde, 7 mg (ie 0.02 mmol) of allylpalladium (II) chloride dimer, 10 mg (ie 0.04 mmol) of triphenylphosphine, and 69 mg (ie 0.5 mmol) of potassium carbonate were added in sequence, and 2 mL of acetonitrile was added. The argon gas was replaced three times, and the mixture was stirred at 80 ° C for 20 hours. After the reaction, the mixture was concentrated and the eluent was petroleum ether: ethyl acetate in a volume ratio of 5:1. The mixture was purified by silica gel column chromatography to obtain 3-((6-fluoro-1-oxo-3-phenyl-1H-isochromen-4-yl)methyl)-1,3-dimethylindolin-2-one, the structure of which is shown in the following formula:
[0042]
[0043] The compound is a white solid with a yield of 63%. Its NMR data are as follows:
[0044] 1 H NMR (600 MHz, CDCl 3 )δ8.14(d,J=8.0Hz,1H),7.44(p,J=3.8Hz,5H),7.33(s,1H),7.28(s,1H),7.12(t,J=7.7Hz,1H),6.75(t,J=7.5Hz,1H),6.59( d,J=7.7Hz,1H),6.45(d,J=7.3Hz,1H),3.53(d,J=15.0Hz,1H),3.38(d,J=14.9Hz,1H),2.89(s,3H),2.42(s,3H),1.24(s,3H). 13 C NMR (151 MHz, CDCl 3)δ180.21,162.10,154.25,144.94,142.69,137.54,133.57,132.31,130.15,129.47,129.42,129.13, 128.35,127.93,125.07,124.02,122.13,117.89,110.08,107.58,48.90,33.73,25.86,23.36,22.12. 19 F NMR (565MHz, CDCl 3 )δ-101.68.
[0045] Example 5
[0046] Synthesis of 3-((3-(4-chlorophenyl)-1-oxo-1H-isochromen-4-yl)methyl)-1,3-dimethylindolin-2-one
[0047] To a 10 mL glass reaction bottle, 152 mg (ie 0.5 mmol) of N-(2-iodophenyl)-N-methylmethylacrylamide, 48 mg (ie 0.2 mmol) of 2-((4-chlorophenyl)ethynyl)benzaldehyde, 7 mg (ie 0.02 mmol) of allylpalladium (II) chloride dimer, 10 mg (ie 0.04 mmol) of triphenylphosphine, and 69 mg (ie 0.5 mmol) of potassium carbonate were added in sequence, and 2 mL of acetonitrile was added. The argon gas was replaced three times, and the mixture was stirred at 80 ° C for 20 hours. After the reaction, the mixture was concentrated and the eluent was petroleum ether:ethyl acetate in a volume ratio of 5:1. The mixture was purified by silica gel column chromatography to obtain 3-((3-(4-chlorophenyl)-1-oxo-1H-isobenzopyran-4-yl)methyl)-1,3-dimethylindolin-2-one, the structure of which is shown in the following formula:
[0048]
[0049] The compound is a yellow liquid with a yield of 64%. Its NMR data are as follows:
[0050] 1 H NMR (600 MHz, CDCl 3)δ8.25(dd,J=7.9,1.4Hz,1H),7.66(td,J=7.6,7.0,1.4Hz,1H),7.62(d,J=8.1H z,1H),7.50-7.45(m,1H),7.40(d,J=8.3Hz,2H),7.32(d,J=8.3Hz,2H),7.12(td, J=7.7,1.2Hz,1H),6.75(t,J=7.5Hz,1H),6.58(d,J=7.7Hz,1H),6.45(d,J=7.3H z,1H),3.47(d,J=15.0Hz,1H),3.39(d,J=14.9Hz,1H),2.85(s,3H),1.27(s,3H). 13 C NMR (151 MHz, CDCl 3 )δ179.81,161.73,152.83,142.72,137.29,135.55,133.92,132.09,131.92,131.42,129.45,128. 66,128.12,128.04,124.87,123.78,122.22,120.32,110.49,107.74,48.89,33.67,25.90,23.53.
[0051] Example 6
[0052] Synthesis of 1,3-dimethyl-3-((3-methyl-1-oxo-1H-isochromen-4-yl)methyl)indolin-2-one
[0053] To a 10 mL glass reaction bottle, 76 mg (ie 0.5 mmol) of N-(2-iodophenyl)-N-methylmethylacrylamide, 29 mg (ie 0.2 mmol) of 2-(prop-1-yn-1-yl)benzaldehyde, 7 mg (ie 0.02 mmol) of allylpalladium (II) chloride dimer, 10 mg (ie 0.04 mmol) of triphenylphosphine, and 69 mg (ie 0.5 mmol) of potassium carbonate were added in sequence, and 2 mL of acetonitrile was added. The argon gas was replaced three times, and the mixture was stirred at 80 ° C for 20 hours. After the reaction, the mixture was concentrated and the eluent was petroleum ether: ethyl acetate in a volume ratio of 5:1. The mixture was purified by silica gel column chromatography to obtain 1,3-dimethyl-3-((3-methyl-1-oxo-1H-isobenzopyran-4-yl)methyl)indolin-2-one, the structure of which is shown in the following formula:
[0054]
[0055] The compound is a yellow liquid with a yield of 63%. Its NMR data are as follows: 1 H NMR (600 MHz, CDCl3 )δ8.25(d,J=7.9Hz,1H),7.60(t,J=7.7Hz,1H),7.49-7.39(m,2H),7.21(t,J=7.7Hz,1H),6.92(d,J=7.4Hz,1H),6.88(t,J=7.4Hz,1H),6.76(d,J=7.8Hz,1H),3.23(d,J=15.2Hz,1H),3.13(s,3H),3.02(d,J=15.2Hz,1H),2.04(s,3H),1.49(s,3H). 13 C NMR(151MHz,CDCl 3 )δ180.19,162.24,153.62,142.91,138.00,133.87,132.57,129.49,128.28,127.15,124.18,123.80,122.11,120.10,108.48,108.02,48.95,33.85,26.16,22.49,18.44。
Claims
1. A method for preparing an indolone-substituted isocoumarin compound, wherein, under an argon atmosphere, under the catalysis of a catalyst and a ligand, in the presence of a base, an N-(2-iodophenyl)-N-methylacrylamide compound represented by formula I and a 2-ethynylbenzaldehyde compound represented by formula II are reacted in an organic solvent to obtain an indolone-substituted isocoumarin compound represented by formula III: in, R 1 For various halogens and alkyl groups, R 2 is an alkyl group or a benzyl group, R 3 For various halogens and alkyl groups, R 4 It is an alkyl group, an aromatic heterocyclic group, a phenyl group and various substituted phenyl groups, and X is a nitrogen or oxygen atom.
2. The preparation method according to claim 1, characterized in that The catalyst is allylpalladium(II) chloride dimer.
3. The preparation method according to claim 1, characterized in that: The amount of allylpalladium(II) chloride dimer used is preferably 10% equivalent to 2-ethynylbenzaldehyde.
4. The preparation method according to claim 1, characterized in that: The ligand is triphenylphosphine.
5. The preparation method according to claim 1, characterized in that: The amount of triphenylphosphine used is preferably 20% equivalent to 2-ethynylbenzaldehyde.
6. The preparation method according to claim 1, characterized in that: The base is potassium carbonate.
7. The preparation method according to claim 1, characterized in that: The amount of potassium carbonate used is preferably 2.5 equivalents of 2-ethynylbenzaldehyde.
8. The preparation method according to claim 1, characterized in that: The molar ratio of the reactants is N-(2-iodophenyl)-N-methylacrylamide:2-ethynylbenzaldehyde compound=2.5:
1.
9. The preparation method according to claim 1, characterized in that: The organic solvent is acetonitrile, and the amount used is 10 ml per mmol of 2-ethynylbenzaldehyde.
10. The preparation method according to claim 1, characterized in that: The reaction temperature was 80°C and the reaction time was 20 hours.
Citation Information
Patent Citations
Alkaloid separated from Tripterygium wilfordii endophytic fungus metabolite and application thereof
CN103288807A
Method for synthesizing indole terpene analogue by palladium-catalyzed tandem Heck / carbonyl ortho-alkylation reaction
CN115340485A
Non-fullerene solar panel acceptor compounds
WO2018140578A1
